Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$905.38 3.66 (0.4%) as of 4:30 Fri 6/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 866.07(B)
Last Volume: 3,374,911 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 50 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2015-11-23 4 OE $56.18 $507,642 D/D 9,036 50,843     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2015-11-20 4 D $83.72 $809,907 D/D (9,674) 55,066     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2015-11-20 4 OE $56.18 $676,857 D/D 12,048 64,740     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-11-20 4 S $84.47 $17,331,231 D/D (205,000) 128,490,804     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-11-13 5 GD $0.00 $0 D/D 10,808 642,549     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2015-11-12 4 D $80.70 $450,225 D/D (5,579) 113,131     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2015-11-12 4 OE $56.18 $389,215 D/D 6,928 118,710     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-11-06 5 GD $0.00 $0 I/I 600 8,384     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-11-05 4/A D $81.05 $316,743 D/D (3,908) 61,200     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-11-05 4 D $81.05 $318,040 D/D (3,924) 61,184     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-11-05 4 OE $56.18 $279,215 D/D 4,970 65,108     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-11-03 4 D $82.04 $4,828,300 D/D (58,853) 666,312     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-11-03 4 OE $56.18 $3,986,758 D/D 70,964 725,165     -
   Alvarez Ralph Director   –       •      –    2015-10-30 4 A $80.25 $9,951 D/D 124 28,365     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-10-29 4 S $81.70 $16,455,724 D/D (200,000) 128,695,804     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-10-26 5 GD $0.00 $0 I/I 322 340,802     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-10-09 4 S $85.84 $18,459,442 D/D (215,000) 128,895,804     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-10-05 4 S $86.25 $22,479,559 D/D (260,000) 129,110,804     -
   Alvarez Ralph Director   –       •      –    2015-09-30 4 A $87.59 $9,898 D/D 113 28,241     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-09-18 4 S $88.92 $22,260,310 D/D (250,000) 129,370,804     -
   Alvarez Ralph Director   –       •      –    2015-08-31 4 A $83.47 $9,933 D/D 119 27,969     -
   Alvarez Ralph Director   –       •      –    2015-07-31 4 A $87.87 $9,929 D/D 113 27,850     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2015-07-30 5 GD $0.00 $0 D/D 963 5,624     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-07-30 4 GD $0.00 $0 D/D 298 666,014     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-07-28 4 S $84.96 $2,124,000 D/D (25,000) 62,728     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 50 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us